Researchers explore the potential of tau-targeting therapies in treating Alzheimer’s disease, focusing on immunotherapies and strategies to improve their efficacy. The study dives into the complex biology of tau proteins, their modifications, and how they can be targeted to halt the progression of Alzheimer’s.
Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts is Fully Operational – Biotech Investments
EQS-News: Rentschler Biopharma SE / Key word(s): Expansion Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts is Fully Operational 11.07.2024 / 14:00 CET/CEST The